Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Effect of Dapagliflozin vs Empagliflozin Administration on Flow Mediated Dilation in Patients With Type 2 Diabetes Mellitus

NCT04195243 is registered in ClinicalTrials.gov with Centro Universitario de Ciencias de la Salud, Mexico as lead sponsor.

NCT NCT04195243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04195243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Effect of Dapagliflozin vs Empagliflozin Administration on Flow Mediated Dilation in Patients With Type 2 Diabetes Mellitus
Lead sponsor
Centro Universitario de Ciencias de la Salud, Mexico
Phase
Phase 3
Overall status
Unknown status
Start date
December 2, 2019
Completion date
December 30, 2020
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus